Wells Fargo & Company Mimedx Group, Inc. Transaction History
Wells Fargo & Company
- $468 Billion
- Q2 2025
A detailed history of Wells Fargo & Company transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 92,975 shares of MDXG stock, worth $686,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,975
Previous 135,889
31.58%
Holding current value
$686,155
Previous $1.03 Million
44.96%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MDXG
# of Institutions
245Shares Held
102MCall Options Held
51.2KPut Options Held
56.8K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$208 Million61.77% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$68.7 Million0.0% of portfolio
-
Trigran Investments, Inc.8.39MShares$61.9 Million9.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.96MShares$51.3 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.45MShares$32.9 Million1.34% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $838M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...